0001104659-19-064171.txt : 20191114
0001104659-19-064171.hdr.sgml : 20191114
20191114160615
ACCESSION NUMBER: 0001104659-19-064171
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191112
FILED AS OF DATE: 20191114
DATE AS OF CHANGE: 20191114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 191220047
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celgene European Investment Co LLC
CENTRAL INDEX KEY: 0001577650
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 191220048
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: 908-673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celgene Switzerland LLC
CENTRAL INDEX KEY: 0001661486
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 191220049
BUSINESS ADDRESS:
STREET 1: AON HOUSE
STREET 2: 30 WOODBOURNE AVENUE
CITY: PEMBROKE
STATE: D0
ZIP: HM 08
BUSINESS PHONE: 4412964803
MAIL ADDRESS:
STREET 1: AON HOUSE
STREET 2: 30 WOODBOURNE AVENUE
CITY: PEMBROKE
STATE: D0
ZIP: HM 08
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celgene Alpine Investment Co., LLC
CENTRAL INDEX KEY: 0001581774
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 191220050
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: X1
ZIP: 07901
BUSINESS PHONE: 908-673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: X1
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20080703
4
1
tm1922788d1_4.xml
FORM 4
X0306
4
2019-11-12
0
0001439222
AGIOS PHARMACEUTICALS, INC.
AGIO
0000816284
CELGENE CORP /DE/
CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
0
1
0
0001577650
Celgene European Investment Co LLC
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
0
1
0
0001661486
Celgene Switzerland LLC
AON HOUSE
30 WOODBOURNE AVENUE
PEMBROKE
D0
HM 08
BERMUDA
0
0
1
0
0001581774
Celgene Alpine Investment Co., LLC
86 MORRIS AVENUE
SUMMIT
X1
07901
0
0
1
0
Common Stock
2019-11-12
4
P
0
403225
31.00
A
1777824
D
Common Stock
624575
I
See footnote
Common Stock
4010926
I
See footnote
Common Stock
708333
I
See footnote
Owned directly by Celgene Switzerland LLC, a wholly-owned subsidiary of Celgene Corporation ("Celgene"). Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
Owned directly by Celgene European Investment Company LLC, a wholly-owned subsidiary of Celgene. Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
Owned directly by Celgene Alpine Investment Co., LLC, a wholly-owned subsidiary of Celgene. Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
/s/ Kevin Mello, Manager, Celgene European Investment Company LLC
2019-11-14
/s/ Kevin Mello, Manager, Celgene Switzerland LLC
2019-11-14
/s/ Kevin Mello, Manager, Celgene Alpine Investment Co., LLC
2019-11-14
/s/ David V. Elkins, Executive Vice President & Chief Financial Officer, Celgene Corporation
2019-11-14